Atopic Dermatitis

Atopic dermatitis associated with different bacteria depending on disease severityNIH investigators find that Staphylococcus epidermidis is predominant in less severe cases, while Staphylococcus aureus is associated with patients who have more severe disease.
Ingredients in eczema topicals pose contact dermatitis riskIngredients used in topical products used to relieve atopic dermatitis in children might put those patients at higher risk for contact dermatitis.
Asthma and food allergies associated with early-onset ADChildren with early-onset atopic dermatitis (AD) have an increased risk of developing asthma and food allergies by age 6 years, especially those with persistent dermatitis symptoms.
Psoriasis and atopic dermatitis respond to IL-17 creamNitric oxide-releasing cream that targets IL-17 moving toward clinical trials.
Relief from the itch in atopic dermatitisAn experimental drug designed to control itching in people with moderate-to-severe AD shows promise in early trial.
Gene mutation identified in atopic dermatitisA new study shows that mutations in the gene CARD11 are associated with severe atopic disease.
House dust mites and severe atopic dermatitis: A new connectionPatients with severe atopic dermatitis who have lower serum vitamin D levels have a high sensitivity to house dust mites which can aggravate their condition, a new study shows.
IL-31 pathway may lead to new treatments for pruritusIn early research, subcutaneous nemolizumab significantly reduced pruritus in moderate-to-severe atopic dermatitis adult patients.
Dupilumab maintains long-term benefits in atopic dermatitis
Dupilumab maintains long-term benefits in atopic dermatitisLong-term data for dupilumab in atopic dermatitis revealed at the American Academy of Dermatology (AAD) 75th Annual Meeting reflect safety, rapid relief of troublesome symptoms and a long-lived response in keeping with the drug’s breakthrough status, experts told Dermatology Times.
Fitting inThe approval of dupilumab (Dupixent, Sanofi Regeneron) for moderate-to-severe atopic dermatitis adds a much-needed option that may alter the broader course of atopic disease, experts told Dermatology Times.

Poll

View Results